BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 12351949)

  • 1. Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif.
    Altfeld MA; Livingston B; Reshamwala N; Nguyen PT; Addo MM; Shea A; Newman M; Fikes J; Sidney J; Wentworth P; Chesnut R; Eldridge RL; Rosenberg ES; Robbins GK; Brander C; Sax PE; Boswell S; Flynn T; Buchbinder S; Goulder PJ; Walker BD; Sette A; Kalams SA
    J Virol; 2001 Feb; 75(3):1301-11. PubMed ID: 11152503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread impact of HLA restriction on immune control and escape pathways of HIV-1.
    Carlson JM; Listgarten J; Pfeifer N; Tan V; Kadie C; Walker BD; Ndung'u T; Shapiro R; Frater J; Brumme ZL; Goulder PJ; Heckerman D
    J Virol; 2012 May; 86(9):5230-43. PubMed ID: 22379086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.
    Kinloch NN; MacMillan DR; Le AQ; Cotton LA; Bangsberg DR; Buchbinder S; Carrington M; Fuchs J; Harrigan PR; Koblin B; Kushel M; Markowitz M; Mayer K; Milloy MJ; Schechter MT; Wagner T; Walker BD; Carlson JM; Poon AF; Brumme ZL
    J Virol; 2016 Feb; 90(3):1244-58. PubMed ID: 26559841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.
    Carlson JM; Brumme CJ; Martin E; Listgarten J; Brockman MA; Le AQ; Chui CK; Cotton LA; Knapp DJ; Riddler SA; Haubrich R; Nelson G; Pfeifer N; Deziel CE; Heckerman D; Apps R; Carrington M; Mallal S; Harrigan PR; John M; Brumme ZL;
    J Virol; 2012 Dec; 86(24):13202-16. PubMed ID: 23055555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-C variants associated with amino acid substitutions in the peptide binding groove influence susceptibility to Kawasaki disease.
    Shimizu C; Kim J; Eleftherohorinou H; Wright VJ; Hoang LT; Tremoulet AH; Franco A; Hibberd ML; Takahashi A; Kubo M; Ito K; Tanaka T; Onouchi Y; Coin LJM; Levin M; Burns JC; Shike H;
    Hum Immunol; 2019 Sep; 80(9):731-738. PubMed ID: 31122742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.
    Scherer A; Frater J; Oxenius A; Agudelo J; Price DA; Günthard HF; Barnardo M; Perrin L; Hirschel B; Phillips RE; McLean AR;
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12266-70. PubMed ID: 15302942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort.
    Zucco AG; Bennedbæk M; Ekenberg C; Gabrielaite M; Leung P; Polizzotto MN; Kan V; Murray DD; Lundgren JD; MacPherson CR;
    AIDS; 2023 Sep; 37(11):1643-1650. PubMed ID: 37534724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of CD8
    Mohamed YS; Borthwick NJ; Moyo N; Murakoshi H; Akahoshi T; Siliquini F; Hannoun Z; Crook A; Hayes P; Fast PE; Mutua G; Jaoko W; Silva-Arrieta S; Llano A; Brander C; Takiguchi M; Hanke T
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32485938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 progression links with viral genetic variability and subtype, and patient's HLA type: analysis of a Nairobi-Kenyan cohort.
    Abidi SH; Shahid A; Lakhani LS; Shah R; Okinda N; Ojwang P; Abbas F; Rowland-Jones S; Ali S
    Med Microbiol Immunol; 2014 Feb; 203(1):57-63. PubMed ID: 24142198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resolution human leukocyte antigen class I allele frequencies and HIV-1 infection associations in Chinese Han and Uyghur cohorts.
    Liu Y; Zhao Z; Li T; Liao Q; Kushner N; Touzjian NY; Shao Y; Sun Y; Strong AJ; Lu Y
    PLoS One; 2012; 7(12):e50656. PubMed ID: 23251376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response.
    Piantadosi A; Chohan B; Panteleeff D; Baeten JM; Mandaliya K; Ndinya-Achola JO; Overbaugh J
    AIDS; 2009 Mar; 23(5):579-87. PubMed ID: 19516110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1.
    Mackelprang RD; John-Stewart G; Carrington M; Richardson B; Rowland-Jones S; Gao X; Mbori-Ngacha D; Mabuka J; Lohman-Payne B; Farquhar C
    J Infect Dis; 2008 Apr; 197(8):1156-61. PubMed ID: 18462163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission.
    Farquhar C; Rowland-Jones S; Mbori-Ngacha D; Redman M; Lohman B; Slyker J; Otieno P; Obimbo E; Rostron T; Ochieng J; Oyugi J; Bosire R; John-Stewart G
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):692-7. PubMed ID: 15307911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades.
    Bird TG; Kaul R; Rostron T; Kimani J; Embree J; Dunn PP; Bwayo JJ; Plummer FA; Rowland-Jones SL; Dong T;
    AIDS; 2002 Sep; 16(14):1899-904. PubMed ID: 12351949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
    Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
    Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.
    Sriwanthana B; Mori M; Tanaka M; Nishimura S; Miura T; Pathipvanich P; Sawanpanyalert P; Ariyoshi K
    PLoS One; 2012; 7(7):e41696. PubMed ID: 22848569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytotoxic T-cells in HIV infection.
    Rowland-Jones S; Dong T; Krausa P; Sutton J; Newell H; Ariyoshi K; Gotch F; Sabally S; Corrah T; Kimani J; MacDonald K; Plummer F; Ndinya-Achola J; Whittle H; McMichael A
    Dev Biol Stand; 1998; 92():209-14. PubMed ID: 9554277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.